228
Participants
Start Date
April 7, 2015
Primary Completion Date
November 30, 2019
Study Completion Date
May 31, 2020
Radiofrequency ablation (RFA)
RFA involves the implantation of electrodes directly into the tumor, with the use of intra-operative ultrasound. The electrodes produce a high frequency alternating current, which leads to frictional heating and thus tissue destruction by thermal coagulation and protein denaturation.
FOLFIRINOX
Oxaliplatin 85mg/m2 given as 2-hour IV infusion, followed by leucovorin 400mg/m2 given as 2-hour IV infusion with addition of irinotecan 180mg/m2 given as 90-minute IV infusion. Followed by fluorouracil 400mg/m2 IV bolus, followed by continuous IV infusion of 2400mg/m2 during 46-hour. Every 2 weeks.
Nab-paclitaxel plus Gemcitabine
Nab-paclitaxel 125mg/m2 given as 30-40-minute IV infusion, followed by gemcitabine 1000mg/m2 IV infusion. On day 1, 8 and 15 every 4 weeks.
Gemcitabine
Gemcitabine 1000mg/m2 given as 30-minute IV infusion. On day 1, 8 and 15 every 4 weeks.
RECRUITING
Amsterdam UMC, Amsterdam
RECRUITING
Regionaal Academisch Kankercentrum Utrecht, Utrecht
Collaborators (1)
Dutch Cancer Society
OTHER
Comprehensive Cancer Centre The Netherlands
OTHER
Olympus
INDUSTRY
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
OTHER